Mylan Pharmaceuticals Inc: Mycophenolate Mofetil For Injection Usp, 500 Mg/vial, Single Dose Vial, 4 Vials Per Carton
Recall Summary Mylan Pharmaceuticals is recalling Mycophenolate Mofetil for Injection USP (500 mg/vial, NDC 67457-386-00) distributed nationwide because the medication contains visible precipitate (particles or cloudiness). This injectable drug is used in patients who have received organ transplants to prevent rejection. The recall affects all states across the United States.
- Recalling firm
- MYLAN PHARMACEUTICALS INC
- Product
- Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00.
- Reason
- Presence of precipitate
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-02
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/a56c64f9-7ee0-4ebf-a613-3d74eafe3a83